Intranuclear inclusions in subtypes of striatal neurons in Huntingtonʼs disease transgenic mice
- 1 December 1999
- journal article
- Published by Wolters Kluwer Health in NeuroReport
- Vol. 10 (18) , 3891-3896
- https://doi.org/10.1097/00001756-199912160-00031
Abstract
R6/2 transgenic mice express exon 1 of an abnormal human Huntington's disease (HD) gene and develop a neurological phenotype similar to HD. These mice develop ubiquitinated neuronal intranuclear inclusions (NII) which might play a central role in the pathophysiology of HD. We studied the distribution of NII in subpopulations of striatal neurons in 12-week-old R6/2 transgenic mice using fluorescent double label immunohistochemistry. We observed that most of the Calbindin-D28K positive projection neurons (89%) and the Parvalbumin positive interneurons (86%) showed ubiquitinated NII. In interneurons, however, which contain either choline acetyltransferase, neuronal nitric oxide synthase, or Calretinin, the frequency of NII was much lower (22%, 8%, 9%, respectively). Our data suggest that subpopulations of striatal neurons differ remarkably in their capability of forming ubiquitinated NII. Interneurons which are known to resist neurodegeneration in HD show less NII.Keywords
This publication has 3 references indexed in Scilit:
- Striatal interneurons in Huntington's disease: Selective increase in the density of calretinin‐immunoreactive medium‐sized neuronsMovement Disorders, 1996
- A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomesCell, 1993
- Calbindin D28K as a marker for the degeneration of the striatonigral pathway in Huntington's diseaseBrain Research, 1990